Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2010 Jul 1;54(Suppl 1):S31–S42. doi: 10.1097/QAI.0b013e3181e3a922

Figure 1.

Figure 1

Phase 1 evaluation of Uc781 gel in young ethnic MSM who have a history of consensual unprotected receptive anal intercourse (RAI). Progression to the evaluation of the UC781 gel is contingent on participants demonstrating ≥ 80% use of placebo product with RAI during Stage 1B.